ID   CP46A_HUMAN             Reviewed;         500 AA.
AC   Q9Y6A2; B4DHP8; E7EQG9; Q8N2B0;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   28-JUN-2023, entry version 192.
DE   RecName: Full=Cholesterol 24-hydroxylase {ECO:0000305|PubMed:14640697};
DE            Short=CH24H;
DE            EC=1.14.14.25 {ECO:0000269|PubMed:10377398, ECO:0000269|PubMed:14640697, ECO:0000269|PubMed:25017465};
DE   AltName: Full=Cholesterol 24-monooxygenase;
DE   AltName: Full=Cholesterol 24S-hydroxylase {ECO:0000303|PubMed:10377398};
DE   AltName: Full=Cytochrome P450 46A1 {ECO:0000303|PubMed:14640697};
GN   Name=CYP46A1 {ECO:0000303|PubMed:20667828,
GN   ECO:0000312|HGNC:HGNC:2641}; Synonyms=CYP46;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=10377398; DOI=10.1073/pnas.96.13.7238;
RA   Lund E.G., Guileyardo J.M., Russell D.W.;
RT   "cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol
RT   homeostasis in the brain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:7238-7243(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Amygdala, and Caudate nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=12077124; DOI=10.1074/jbc.m201712200;
RA   Bodin K., Andersson U., Rystedt E., Ellis E., Norlin M., Pikuleva I.,
RA   Eggertsen G., Bjoerkhem I., Diczfalusy U.;
RT   "Metabolism of 4 beta -hydroxycholesterol in humans.";
RL   J. Biol. Chem. 277:31534-31540(2002).
RN   [6]
RP   CHARACTERIZATION, BIOPHYSICOCHEMICAL PROPERTIES, FUNCTION, CATALYTIC
RP   ACTIVITY, AND PATHWAY.
RX   PubMed=14640697; DOI=10.1021/bi035512f;
RA   Mast N., Norcross R., Andersson U., Shou M., Nakayama K., Bjoerkhem I.,
RA   Pikuleva I.A.;
RT   "Broad substrate specificity of human cytochrome P450 46A1 which initiates
RT   cholesterol degradation in the brain.";
RL   Biochemistry 42:14284-14292(2003).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=25017465; DOI=10.1194/jlr.m051508;
RA   Goyal S., Xiao Y., Porter N.A., Xu L., Guengerich F.P.;
RT   "Oxidation of 7-dehydrocholesterol and desmosterol by human cytochrome P450
RT   46A1.";
RL   J. Lipid Res. 55:1933-1943(2014).
RN   [8]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=28190002; DOI=10.1074/jbc.m116.774760;
RA   Mast N., Anderson K.W., Lin J.B., Li Y., Turko I.V., Tatsuoka C.,
RA   Bjorkhem I., Pikuleva I.A.;
RT   "Cytochrome P450 27A1 Deficiency and Regional Differences in Brain Sterol
RT   Metabolism Cause Preferential Cholestanol Accumulation in the Cerebellum.";
RL   J. Biol. Chem. 292:4913-4924(2017).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 51-500 IN COMPLEX WITH HEME AND
RP   CHOLESTEROL 3-SULFATE, CATALYTIC ACTIVITY, FUNCTION, AND COFACTOR.
RX   PubMed=18621681; DOI=10.1073/pnas.0803717105;
RA   Mast N., White M.A., Bjorkhem I., Johnson E.F., Stout C.D., Pikuleva I.A.;
RT   "Crystal structures of substrate-bound and substrate-free cytochrome P450
RT   46A1, the principal cholesterol hydroxylase in the brain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:9546-9551(2008).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 51-500 IN COMPLEXES WITH HEME AND
RP   INHIBITORS, FUNCTION, AND COFACTOR.
RX   PubMed=20667828; DOI=10.1074/jbc.m110.143313;
RA   Mast N., Charvet C., Pikuleva I.A., Stout C.D.;
RT   "Structural basis of drug binding to CYP46A1, an enzyme that controls
RT   cholesterol turnover in the brain.";
RL   J. Biol. Chem. 285:31783-31795(2010).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 51-500 IN COMPLEXES WITH HEME AND
RP   THE INHIBITOR BICALUTAMIDE, AND COFACTOR.
RX   PubMed=23288837; DOI=10.1074/jbc.m112.438754;
RA   Mast N., Zheng W., Stout C.D., Pikuleva I.A.;
RT   "Binding of a cyano- and fluoro-containing drug bicalutamide to cytochrome
RT   P450 46A1: unusual features and spectral response.";
RL   J. Biol. Chem. 288:4613-4624(2013).
CC   -!- FUNCTION: P450 monooxygenase that plays a major role in cholesterol
CC       homeostasis in the brain. Primarily catalyzes the hydroxylation (with S
CC       stereochemistry) at C-24 of cholesterol side chain, triggering
CC       cholesterol diffusion out of neurons and its further degradation
CC       (PubMed:10377398, PubMed:14640697, PubMed:25017465, PubMed:18621681).
CC       By promoting constant cholesterol elimination in neurons, may activate
CC       the mevalonate pathway and coordinate the synthesis of new cholesterol
CC       and nonsterol isoprenoids involved in synaptic activity and learning
CC       (By similarity). Further hydroxylates cholesterol derivatives and
CC       hormone steroids on both the ring and side chain of these molecules,
CC       converting them into active oxysterols involved in lipid signaling and
CC       biosynthesis (PubMed:12077124, PubMed:14640697, PubMed:28190002). Acts
CC       as an epoxidase converting cholesta-5,24-dien-3beta-ol/desmosterol into
CC       (24S),25-epoxycholesterol, an abundant lipid ligand of nuclear NR1H2
CC       and NR1H3 receptors shown to promote neurogenesis in developing brain
CC       (PubMed:25017465). May also catalyze the oxidative metabolism of
CC       xenobiotics, such as clotrimazole (PubMed:20667828).
CC       {ECO:0000250|UniProtKB:Q9WVK8, ECO:0000269|PubMed:10377398,
CC       ECO:0000269|PubMed:12077124, ECO:0000269|PubMed:14640697,
CC       ECO:0000269|PubMed:18621681, ECO:0000269|PubMed:20667828,
CC       ECO:0000269|PubMed:25017465, ECO:0000269|PubMed:28190002}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=cholesterol + O2 + reduced [NADPH--hemoprotein reductase] =
CC         (24S)-hydroxycholesterol + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:22716, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16113, ChEBI:CHEBI:34310, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210; EC=1.14.14.25;
CC         Evidence={ECO:0000269|PubMed:10377398, ECO:0000269|PubMed:14640697,
CC         ECO:0000269|PubMed:18621681, ECO:0000269|PubMed:25017465};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22717;
CC         Evidence={ECO:0000250|UniProtKB:Q9WVK8};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=cholestanol + O2 + reduced [NADPH--hemoprotein reductase] =
CC         (24S)-hydroxycholestanol + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:53808, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:86570,
CC         ChEBI:CHEBI:137687; Evidence={ECO:0000269|PubMed:28190002};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53809;
CC         Evidence={ECO:0000250|UniProtKB:Q9WVK8};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=7-dehydrocholesterol + O2 + reduced [NADPH--hemoprotein
CC         reductase] = cholesta-5,7-dien-3beta,24S-diol + H(+) + H2O + oxidized
CC         [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:53244, Rhea:RHEA-
CC         COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:17759,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:137061;
CC         Evidence={ECO:0000269|PubMed:25017465};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53245;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=7-dehydrocholesterol + O2 + reduced [NADPH--hemoprotein
CC         reductase] = cholesta-5,7-dien-3beta,25-diol + H(+) + H2O + oxidized
CC         [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:53240, Rhea:RHEA-
CC         COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:17759,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:137057;
CC         Evidence={ECO:0000269|PubMed:25017465};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53241;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=desmosterol + O2 + reduced [NADPH--hemoprotein reductase] =
CC         (24Z),26-hydroxydesmosterol + H(+) + H2O + oxidized
CC         [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:53236, Rhea:RHEA-
CC         COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:17737,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:137053;
CC         Evidence={ECO:0000269|PubMed:25017465};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53237;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=desmosterol + O2 + reduced [NADPH--hemoprotein reductase] =
CC         (24S)-25-epoxycholesterol + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:53232, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:17737, ChEBI:CHEBI:41633, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210; Evidence={ECO:0000269|PubMed:25017465};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53233;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4beta-hydroxycholesterol + O2 + reduced [NADPH--hemoprotein
CC         reductase] = 4beta,24S-dihydroxycholesterol + H(+) + H2O + oxidized
CC         [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:46392, Rhea:RHEA-
CC         COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210, ChEBI:CHEBI:85778, ChEBI:CHEBI:86087;
CC         Evidence={ECO:0000269|PubMed:12077124};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46393;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(24S)-hydroxycholesterol + O2 + reduced [NADPH--hemoprotein
CC         reductase] = (24S,25R)-24,26-dihydroxycholesterol + H(+) + H2O +
CC         oxidized [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:46388,
CC         Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:34310,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:86165;
CC         Evidence={ECO:0000269|PubMed:14640697};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46389;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(24S)-hydroxycholesterol + O2 + reduced [NADPH--hemoprotein
CC         reductase] = 24S,25-dihydroxycholesterol + H(+) + H2O + oxidized
CC         [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:46384, Rhea:RHEA-
CC         COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:34310,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:86074;
CC         Evidence={ECO:0000269|PubMed:14640697, ECO:0000269|PubMed:18621681};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46385;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=7alpha-hydroxycholesterol + O2 + reduced [NADPH--hemoprotein
CC         reductase] = (24S)-7alpha-dihydroxycholesterol + H(+) + H2O +
CC         oxidized [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:46380,
CC         Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:17500,
CC         ChEBI:CHEBI:37640, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000269|PubMed:14640697};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46381;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + progesterone + reduced [NADPH--hemoprotein reductase] =
CC         17alpha-hydroxyprogesterone + H(+) + H2O + oxidized
CC         [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:46308, Rhea:RHEA-
CC         COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:17026,
CC         ChEBI:CHEBI:17252, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000269|PubMed:14640697};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46309;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + reduced [NADPH--hemoprotein reductase] + testosterone =
CC         16beta,17beta-dihydroxyandrost-4-en-3-one + H(+) + H2O + oxidized
CC         [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:46304, Rhea:RHEA-
CC         COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:17347,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:83027;
CC         Evidence={ECO:0000269|PubMed:14640697};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46305;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + reduced [NADPH--hemoprotein reductase] + testosterone =
CC         2-hydroxytestosterone + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:46300, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:17347, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:86013; Evidence={ECO:0000269|PubMed:14640697};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46301;
CC         Evidence={ECO:0000305};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + reduced [NADPH--hemoprotein reductase] + testosterone =
CC         6beta,17beta-dihydroxyandrost-4-en-3-one + H(+) + H2O + oxidized
CC         [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:46296, Rhea:RHEA-
CC         COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:17347,
CC         ChEBI:CHEBI:34477, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000269|PubMed:14640697};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46297;
CC         Evidence={ECO:0000305};
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000269|PubMed:18621681, ECO:0000269|PubMed:20667828,
CC         ECO:0000269|PubMed:23288837};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.2 uM for 24(S)-hydroxycholesterol {ECO:0000269|PubMed:14640697};
CC         KM=7 uM for cholesterol {ECO:0000269|PubMed:25017465};
CC         KM=2.8 uM for cholesta-5,7-dien-3beta-ol/7-dehydrocholesterol
CC         {ECO:0000269|PubMed:25017465};
CC         KM=9.4 uM for cholesta-5,24-dien-3beta-ol/desmosterol
CC         {ECO:0000269|PubMed:25017465};
CC         Note=kcat/KM=8.4 mM/min for cholesterol, kcat/KM=8.5 mM/min for
CC         cholesta-5,7-dien-3beta-ol/7-dehydrocholesterol and kcat/KM=3.5
CC         mM/min for cholesta-5,24-dien-3beta-ol/desmosterol.
CC         {ECO:0000269|PubMed:25017465};
CC   -!- PATHWAY: Steroid metabolism; cholesterol degradation.
CC       {ECO:0000305|PubMed:14640697}.
CC   -!- PATHWAY: Lipid metabolism; C21-steroid hormone metabolism.
CC       {ECO:0000305|PubMed:14640697}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q9WVK8}; Single-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9WVK8}. Microsome membrane
CC       {ECO:0000250|UniProtKB:Q9WVK8}; Single-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q9WVK8}. Postsynapse
CC       {ECO:0000250|UniProtKB:Q9WVK8}. Presynapse
CC       {ECO:0000250|UniProtKB:Q9WVK8}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q9WVK8}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9Y6A2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y6A2-2; Sequence=VSP_053859;
CC       Name=3;
CC         IsoId=Q9Y6A2-3; Sequence=VSP_053858, VSP_053860;
CC   -!- TISSUE SPECIFICITY: Expressed in brain. The mRNA was broadly
CC       distributed with higher levels in gray matter zones and lower levels in
CC       regions rich in white matter. Not detected in fetal sample but its
CC       expression increases linearly with age. {ECO:0000269|PubMed:10377398}.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF094480; AAD41244.1; -; mRNA.
DR   EMBL; AK090886; BAC03539.1; -; mRNA.
DR   EMBL; AK295216; BAG58210.1; -; mRNA.
DR   EMBL; AL136000; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL160313; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC022539; AAH22539.1; -; mRNA.
DR   CCDS; CCDS9954.1; -. [Q9Y6A2-1]
DR   RefSeq; NP_006659.1; NM_006668.1. [Q9Y6A2-1]
DR   PDB; 2Q9F; X-ray; 1.90 A; A=51-500.
DR   PDB; 2Q9G; X-ray; 2.40 A; A=51-500.
DR   PDB; 3MDM; X-ray; 1.60 A; A=51-500.
DR   PDB; 3MDR; X-ray; 2.00 A; A/B=51-500.
DR   PDB; 3MDT; X-ray; 2.30 A; A/B=51-500.
DR   PDB; 3MDV; X-ray; 2.40 A; A/B=51-500.
DR   PDB; 4ENH; X-ray; 2.50 A; A=51-500.
DR   PDB; 4FIA; X-ray; 2.10 A; A=51-500.
DR   PDB; 4J14; X-ray; 2.50 A; A=51-500.
DR   PDB; 7LRL; X-ray; 2.00 A; A=28-494.
DR   PDB; 7LS3; X-ray; 2.15 A; A=28-494.
DR   PDB; 7LS4; X-ray; 2.05 A; A=28-494.
DR   PDB; 7N3L; X-ray; 1.63 A; A=28-494.
DR   PDB; 7N3M; X-ray; 1.70 A; AAA=28-494.
DR   PDB; 7N6F; X-ray; 1.40 A; A=28-494.
DR   PDBsum; 2Q9F; -.
DR   PDBsum; 2Q9G; -.
DR   PDBsum; 3MDM; -.
DR   PDBsum; 3MDR; -.
DR   PDBsum; 3MDT; -.
DR   PDBsum; 3MDV; -.
DR   PDBsum; 4ENH; -.
DR   PDBsum; 4FIA; -.
DR   PDBsum; 4J14; -.
DR   PDBsum; 7LRL; -.
DR   PDBsum; 7LS3; -.
DR   PDBsum; 7LS4; -.
DR   PDBsum; 7N3L; -.
DR   PDBsum; 7N3M; -.
DR   PDBsum; 7N6F; -.
DR   AlphaFoldDB; Q9Y6A2; -.
DR   SMR; Q9Y6A2; -.
DR   BioGRID; 116069; 4.
DR   IntAct; Q9Y6A2; 1.
DR   STRING; 9606.ENSP00000261835; -.
DR   BindingDB; Q9Y6A2; -.
DR   ChEMBL; CHEMBL4523510; -.
DR   GuidetoPHARMACOLOGY; 1373; -.
DR   SwissLipids; SLP:000001220; -. [Q9Y6A2-1]
DR   SwissLipids; SLP:000001720; -.
DR   GlyGen; Q9Y6A2; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; Q9Y6A2; -.
DR   PhosphoSitePlus; Q9Y6A2; -.
DR   BioMuta; CYP46A1; -.
DR   DMDM; 12585217; -.
DR   MassIVE; Q9Y6A2; -.
DR   PaxDb; Q9Y6A2; -.
DR   PeptideAtlas; Q9Y6A2; -.
DR   ProteomicsDB; 4238; -.
DR   ProteomicsDB; 71672; -.
DR   ProteomicsDB; 86640; -. [Q9Y6A2-1]
DR   Antibodypedia; 14316; 340 antibodies from 31 providers.
DR   DNASU; 10858; -.
DR   Ensembl; ENST00000261835.8; ENSP00000261835.3; ENSG00000036530.9. [Q9Y6A2-1]
DR   Ensembl; ENST00000380228.6; ENSP00000369577.3; ENSG00000036530.9. [Q9Y6A2-2]
DR   GeneID; 10858; -.
DR   KEGG; hsa:10858; -.
DR   MANE-Select; ENST00000261835.8; ENSP00000261835.3; NM_006668.2; NP_006659.1.
DR   UCSC; uc001ygo.4; human. [Q9Y6A2-1]
DR   AGR; HGNC:2641; -.
DR   CTD; 10858; -.
DR   DisGeNET; 10858; -.
DR   GeneCards; CYP46A1; -.
DR   HGNC; HGNC:2641; CYP46A1.
DR   HPA; ENSG00000036530; Tissue enriched (brain).
DR   MIM; 604087; gene.
DR   neXtProt; NX_Q9Y6A2; -.
DR   OpenTargets; ENSG00000036530; -.
DR   PharmGKB; PA27117; -.
DR   VEuPathDB; HostDB:ENSG00000036530; -.
DR   eggNOG; KOG0157; Eukaryota.
DR   GeneTree; ENSGT00940000156927; -.
DR   InParanoid; Q9Y6A2; -.
DR   OMA; IAGRTMF; -.
DR   OrthoDB; 1611592at2759; -.
DR   PhylomeDB; Q9Y6A2; -.
DR   TreeFam; TF352037; -.
DR   BRENDA; 1.14.14.25; 2681.
DR   PathwayCommons; Q9Y6A2; -.
DR   Reactome; R-HSA-193775; Synthesis of bile acids and bile salts via 24-hydroxycholesterol.
DR   Reactome; R-HSA-211976; Endogenous sterols.
DR   SABIO-RK; Q9Y6A2; -.
DR   SignaLink; Q9Y6A2; -.
DR   UniPathway; UPA00229; -.
DR   UniPathway; UPA01058; -.
DR   BioGRID-ORCS; 10858; 5 hits in 1146 CRISPR screens.
DR   ChiTaRS; CYP46A1; human.
DR   EvolutionaryTrace; Q9Y6A2; -.
DR   GeneWiki; CYP46A1; -.
DR   GenomeRNAi; 10858; -.
DR   Pharos; Q9Y6A2; Tchem.
DR   PRO; PR:Q9Y6A2; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q9Y6A2; protein.
DR   Bgee; ENSG00000036530; Expressed in middle temporal gyrus and 126 other tissues.
DR   ExpressionAtlas; Q9Y6A2; baseline and differential.
DR   Genevisible; Q9Y6A2; HS.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; TAS:ProtInc.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0098794; C:postsynapse; ISS:UniProtKB.
DR   GO; GO:0098793; C:presynapse; ISS:UniProtKB.
DR   GO; GO:0033781; F:cholesterol 24-hydroxylase activity; IDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IDA:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0008395; F:steroid hydroxylase activity; IDA:UniProtKB.
DR   GO; GO:0062184; F:testosterone 16-beta-hydroxylase activity; IEA:RHEA.
DR   GO; GO:0006699; P:bile acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0006707; P:cholesterol catabolic process; IDA:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0042448; P:progesterone metabolic process; IDA:UniProtKB.
DR   GO; GO:1903044; P:protein localization to membrane raft; ISS:ARUK-UCL.
DR   GO; GO:1900271; P:regulation of long-term synaptic potentiation; ISS:UniProtKB.
DR   GO; GO:0016125; P:sterol metabolic process; TAS:Reactome.
DR   GO; GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB.
DR   CDD; cd20613; CYP46A1-like; 1.
DR   Gene3D; 1.10.630.10; Cytochrome P450; 1.
DR   InterPro; IPR039983; CYP46A1.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   InterPro; IPR036396; Cyt_P450_sf.
DR   PANTHER; PTHR24293:SF1; CHOLESTEROL 24-HYDROXYLASE; 1.
DR   PANTHER; PTHR24293; CYTOCHROME P450 FAMILY 46 SUBFAMILY A; 1.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; Cytochrome P450; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell projection;
KW   Cholesterol metabolism; Endoplasmic reticulum; Heme; Iron;
KW   Lipid metabolism; Membrane; Metal-binding; Microsome; Monooxygenase;
KW   Oxidoreductase; Reference proteome; Steroid metabolism; Sterol metabolism;
KW   Synapse; Transmembrane; Transmembrane helix.
FT   CHAIN           1..500
FT                   /note="Cholesterol 24-hydroxylase"
FT                   /id="PRO_0000051994"
FT   TRANSMEM        3..23
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   BINDING         437
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000269|PubMed:18621681,
FT                   ECO:0000269|PubMed:20667828, ECO:0000269|PubMed:23288837,
FT                   ECO:0007744|PDB:2Q9F, ECO:0007744|PDB:2Q9G,
FT                   ECO:0007744|PDB:3MDR, ECO:0007744|PDB:3MDT,
FT                   ECO:0007744|PDB:3MDV, ECO:0007744|PDB:4ENH,
FT                   ECO:0007744|PDB:4FIA, ECO:0007744|PDB:4J14"
FT   VAR_SEQ         1..153
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_053858"
FT   VAR_SEQ         1..97
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_053859"
FT   VAR_SEQ         383..392
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_053860"
FT   TURN            29..32
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           60..71
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   STRAND          73..79
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   STRAND          82..87
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           90..97
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           106..109
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           110..113
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   STRAND          118..121
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   TURN            125..127
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           131..141
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           142..145
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           147..151
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           154..169
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   STRAND          173..176
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           180..197
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           203..205
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           209..226
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   TURN            227..229
FT                   /evidence="ECO:0007829|PDB:2Q9F"
FT   HELIX           230..232
FT                   /evidence="ECO:0007829|PDB:3MDM"
FT   HELIX           234..236
FT                   /evidence="ECO:0007829|PDB:3MDM"
FT   HELIX           237..266
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           275..282
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   TURN            283..285
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   STRAND          287..289
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           290..318
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           322..335
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   TURN            336..338
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           344..349
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           351..363
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   STRAND          369..374
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   STRAND          378..380
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   STRAND          383..385
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   STRAND          387..394
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           395..399
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   TURN            402..404
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   STRAND          405..407
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           413..416
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   STRAND          424..426
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   HELIX           433..435
FT                   /evidence="ECO:0007829|PDB:3MDM"
FT   HELIX           440..457
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   STRAND          458..462
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   STRAND          470..480
FT                   /evidence="ECO:0007829|PDB:7N6F"
FT   STRAND          483..488
FT                   /evidence="ECO:0007829|PDB:7N6F"
SQ   SEQUENCE   500 AA;  56821 MW;  AB9307749D9E5FDA CRC64;
     MSPGLLLLGS AVLLAFGLCC TFVHRARSRY EHIPGPPRPS FLLGHLPCFW KKDEVGGRVL
     QDVFLDWAKK YGPVVRVNVF HKTSVIVTSP ESVKKFLMST KYNKDSKMYR ALQTVFGERL
     FGQGLVSECN YERWHKQRRV IDLAFSRSSL VSLMETFNEK AEQLVEILEA KADGQTPVSM
     QDMLTYTAMD ILAKAAFGME TSMLLGAQKP LSQAVKLMLE GITASRNTLA KFLPGKRKQL
     REVRESIRFL RQVGRDWVQR RREALKRGEE VPADILTQIL KAEEGAQDDE GLLDNFVTFF
     IAGHETSANH LAFTVMELSR QPEIVARLQA EVDEVIGSKR YLDFEDLGRL QYLSQVLKES
     LRLYPPAWGT FRLLEEETLI DGVRVPGNTP LLFSTYVMGR MDTYFEDPLT FNPDRFGPGA
     PKPRFTYFPF SLGHRSCIGQ QFAQMEVKVV MAKLLQRLEF RLVPGQRFGL QEQATLKPLD
     PVLCTLRPRG WQPAPPPPPC
//
